Cookie Notice

We use cookies on this site. By continuing to browse without changing your browser settings to block or delete cookies, you agree to the UW–Madison Cookie Notice.
Skip to main content
University of Wisconsin–Madison
UW Crest
Ophthalmology and Visual Sciences
  • Home
  • About Us Expand Collapse
    • About Us
    • Alumni
    • Careers
    • Directory
    • Giving
    • Leadership
  • Education Expand Collapse
    • Clinical Fellowships
    • Global Ophthalmology
    • Ophthalmology Clerkship
    • Orthoptist Training Program
    • Pre-Residency Fellowships
    • Residency Program
    • Vision Research Opportunities
    • Vision Research Training Program
    • Visiting Medical Students
  • Research Expand Collapse
    • A-EYE Research Unit
    • Clinical Eye Research Unit
    • Laboratories
    • Publications
    • Research Resources
    • Vision Research Core
    • Vision Research Training Program
    • WAIVS
    • Wisconsin Reading Center
  • Global Ophthalmology
  • People First
  • Events
  • Giving
  • News

IONIS-FB-LRx

Posted on June 12, 2019

The purpose of the study is to evaluate the effect of IONIS-FB-LRx on the rate of change of the area of geographic atrophy (GA) secondary to age-related macular degeneration (AMD) measured by fundus autofluorescence (FAF).

Sponsor: Ionis Pharmaceuticals, Inc.

CLINICALTRIALS.GOV

 

Posted in Age-related Macular Degeneration, Clinical Trials, Kimberly Stepien, Past

Post navigation

Previous post: DERBY/GALE
Next post: KESTREL

Archives

Categories

Site footer content



University logo that links to main university website


Quick Links

  • News
  • Contact Us
  • Giving
  • Intranet Login
  • UW-Madison School of Medicine and Public Health

Contact Us

  • 2828 Marshall Court
    Madison, WI 53705
    • facebook
    • instagram
    • linkedin

Website feedback, questions or accessibility issues: webmaster@ophth.wisc.edu.

This site was built using the UW Theme | Privacy Notice | © 2025 Board of Regents of the University of Wisconsin System.